This year’s landmark climate gathering, the 30th session of the COP30, convenes in the Amazon city of Belém, Brazil. Far more than a routine global meeting, the event arrives at a moment when the urgency of climate action intersects with geopolitical complexity, financial shortfalls and rising demands for justice. The question now is not just…
Amid volatility in technology stocks and whispers of rotation toward value sectors, State Street Global Advisors maintains that the artificial intelligence (AI) rally is far from over. The Boston-based asset manager argues that despite intermittent pullbacks, the underlying structure of the AI-driven market remains intact — a function of deep capital expenditure cycles, investor psychology,…
In a bold strategic move designed to reposition itself in the booming weight-loss therapeutics market, Pfizer Inc. has secured the acquisition of Metsera, Inc., outbidding its rival Novo Nordisk A/S in a contest that underscores how and why the pharmaceutical giant is shifting its growth playbook. The deal marks more than just an asset purchase—it…
Negotiations between YouTube TV and The Walt Disney Company have entered a critical phase as YouTube publicly stated it is ready to cut a binding deal to restore Disney’s networks — including ABC and ESPN — to its live-TV platform in the United States. The dispute has exposed deeper shifts in carriage-fee leverage, streaming business…
Russia’s wine market is undergoing a profound transformation. Once brimming with French Burgundies, Italian Barolos and South American imports, supermarket shelves now showcase mainly Russian-made vintages. The shift, punctuated by Western sanctions after the invasion of Ukraine in early 2022, is not simply a consumer re-orientation—it embodies changing trade flows, protectionist impulses and a broader…
Eli Lilly’s injectable weight-loss drug Mounjaro has rapidly overtaken established pharmaceuticals in India’s competitive market, emerging as the country’s top-selling drug by value in October 2025. The milestone reflects a seismic shift in healthcare priorities among Indian consumers and doctors, where chronic diseases and body-weight management have become central medical and social concerns. Mounjaro’s rise…
China’s manufacturing sector sank deeper in October, with the official Purchasing Managers’ Index (PMI) falling to 49.0—its weakest reading in six months and below economists’ expectations. The downturn continues a contractionary streak that now stretches into its seventh consecutive month, highlighting how external shocks, weak domestic demand and structural challenges are converging to test the…
In a bold move aimed at transforming its manufacturing landscape, Samsung Electronics has announced plans to build an “AI Megafactory” powered by more than 50,000 advanced GPUs supplied by Nvidia Corporation. The facility is designed to embed artificial intelligence across Samsung’s semiconductor-, mobile-device and robotics-manufacturing operations, signalling one of the most aggressive industrial AI deployments…
Leading chipmaker Nvidia has struck a major agreement to supply more than 260,000 of its cutting-edge Blackwell-architecture AI chips to South Korea, representing one of the most substantial single-market deployments of its latest technology to date. The deal involves both the Korean government and some of the country’s largest corporations—including Samsung Electronics, SK Group and…
Eli Lilly has raised its full-year revenue and profit forecasts after booming sales of its weight-loss and diabetes medications, Zepbound and Mounjaro, propelled earnings beyond expectations. The company’s shares jumped sharply in premarket trading, reflecting growing investor confidence in the power of a new class of metabolic treatments that have rapidly transformed the healthcare landscape.…
business-gurus.com 